Article
Targeted multiplex proteomics for the development and validation of biomarkers in primary aldosteronism subtyping
18 Nov 2024
Abstract excerpt
OBJECTIVE: Primary aldosteronism (PA), a significant cause of secondary hypertension affecting ∼10% of patients with severe hypertension, exacerbates cardiovascular, and cerebrovascular complications even after blood pressure control. PA is categorized into two main subtypes: unilateral aldosterone-producing adenomas (APA) and bilateral hyperaldosteronism (BHA), each requiring distinct treatment approaches....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
